Veterinary Medicine in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
Veterinary medicine is concerned with preventing, controlling, diagnosing, and treating diseases affecting the health of both food-producing and companion animals and preventing the transmission of animal diseases to humans. Market value represents revenue generated by market players in a specific year.
The Asia-Pacific veterinary medicine market recorded revenues of $5,098.9 million in 2023, representing a compound annual growth rate (CAGR) of 3.5% between 2018 and 2023.
The pharmaceutical segment accounted for the market's largest proportion in 2023, with total revenues of $3,197.3 million, equivalent to 62.7% of the market's overall value.
The Asia-Pacific market experienced growth driven by the rising trend of pet ownership, which notably boosts demand for veterinary services and pet health products. For example, according to the Asian Animal Health Association (AAHA), pet ownership in Asia is significant, with 60% of households owning at least one pet.
Scope
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the veterinary medicine market in Asia-Pacific
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the veterinary medicine market in Asia-Pacific
Leading company profiles reveal details of key veterinary medicine market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific veterinary medicine market with five year forecasts
Reasons to Buy
What was the size of the Asia-Pacific veterinary medicine market by value in 2023?
What will be the size of the Asia-Pacific veterinary medicine market in 2028?
What factors are affecting the strength of competition in the Asia-Pacific veterinary medicine market?
How has the market performed over the last five years?
What are the main segments that make up Asia-Pacific's veterinary medicine market?
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do the leading players follow?
7.3. What have been the most recent market developments?
8 Company Profiles
8.1. Zoetis Inc
8.2. Merck & Co., Inc.
8.3. China National Pharmaceutical Group Corp
8.4. Boehringer Ingelheim GmbH
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related GlobalData research
10.4. About GlobalData
List of Tables
Table 1: Asia-Pacific veterinary medicine market value: $ million, 2018-23
Table 2: Asia-Pacific veterinary medicine market category segmentation: % share, by value, 2018-23